WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001030339) USE OF 1-AMINOINDAN DERIVATIVES FOR TREATMENT OF MANIA IN BIPOLAR MOOD DISORDER
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/030339    International Application No.:    PCT/US2000/029618
Publication Date: 03.05.2001 International Filing Date: 27.10.2000
Chapter 2 Demand Filed:    19.04.2001    
IPC:
A61K 31/16 (2006.01), A61K 31/165 (2006.01), A61K 31/166 (2006.01)
Applicants: TEVA PHARMACEUTICAL INDUSTRIES, LTD. [IL/IL]; 5 Basel Street, P.O. Box 3190, 49131 Petah Tiqva (IL) (AE, AG, AL, AM, AT, AU, AZ, BA, BE, BF, BG, BJ, BR, BY, BZ, CA, CF, CG, CH, CI, CM, CN, CR, CU, CY, CZ, DE, DK, DM, DZ, EE, ES, FI, FR, GA, GB, GD, GE, GH, GM, GN, GR, GW, HR, HU, ID, IE, IL, IN, IS, IT, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MC, MD, MG, MK, ML, MN, MR, MW, MX, MZ, NE, NL, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, SN, SZ, TD, TG, TJ, TM, TR, TT, TZ, UA, UG, UZ, VN, YU, ZA, ZW only).
TEVA PHARMACEUTICALS USA, INC. [US/US]; 650 Cathill Road, Sellersville, PA 18960 (US) (BB only).
BARAK, Gabriela [IL/IL]; (IL) (For US Only).
LEVY, Ruth [IL/IL]; (IL) (For US Only)
Inventors: BARAK, Gabriela; (IL).
LEVY, Ruth; (IL)
Agent: WHITE, John, P.; Cooper & Dunham LLP, 1185 Avenue of the Americas, New York, NY 10036 (US)
Priority Data:
60/161,817 27.10.1999 US
Title (EN) USE OF 1-AMINOINDAN DERIVATIVES FOR TREATMENT OF MANIA IN BIPOLAR MOOD DISORDER
(FR) UTILISATION DE DERIVES DE 1-AMINOINDAN POUR LE TRAITEMENT DE LA MANIE LIÉE À LA PSYCHOSE MANIACODÉPRESSIVE
Abstract: front page image
(EN)The subject invention provides a method of treating mania in bipolar disorder in a subject comprising administering to the subject a therapeutically effective amount of derivatives of 1-aminoindan or their racemic mixtures, enantiomers, or salts, of general formula (I).
(FR)La présente invention concerne le traitement de la manie liée à la psychose maniacodépressive chez sujet par administration d'une quantité suffisante de dérivés de 1-aminoindan représentés par la formule générale (I).
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)